I spoke to Pierre van Weperen who is Managing Director at Grow Biotech UK and Chair of the Board at Dutch National MS Society.
Grow Biotech are working with manufacturers to make a broad range of medicinal cannabis products available in the UK and their R&D team creates and patents new technologies for Medicinal Cannabis producers to create better, cost-effective medicines.
Pierre talked passionately about unlocking the potential of medicinal cannabis, making it available for those who need it in an affordable way.
This has been a hot topic in the industry for years. I previously spoke about it in my article "Why Cannabis Is a Risk Worth Taking for Big Pharma". You can find more of my content that covers the pharmaceutical and specialty chemicals markets here.
If you’d like to get involved in the conversation, send us an email to cmconversations@charltonmorris.com
.jpg)
In a space of increased innovation in drug delivery, I took a deeper look into the leading products taking the market by storm.
Are you attracting the very best industry talent to your start-up? For expert advice on how to thrive in today’s life science talent market, watch CM Life Science's latest 30-minute webinar. Click to watch.
What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.
Comments.